Abstract:Introductıon While kidney cancer is the third most common cancer among urogenital cancers, it ranks seventeen among the most common cancers (1). Although kidney cancer patients usually have good outcomes after surgical intervention, less than 20% of individuals with advanced disease have a 2-year survival. Kidney cancer is seen twice in men than in women (2). Kidney cancer is not a single type of cancer and it has genetically and histologically different types responding to therapy differently due to mutations… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.